Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Elixir Pharmaceuticals, Inc
Download detailed PDF Members: We are a biopharmaceutical company utilizing aging research to develop pharmaceuticals that treat and/or prevent metabolic diseases such as obesity and diabetes. Our technology is based on the recent discovery that aging is genetically controlled and is intimately related to the diseases of obesity and diabetes. We have identified many of the genes that regulate aging and the pathways and proteins encoded by these longevity genes are the targets of our drug discovery efforts.
This page has been viewed 402 times since April 2007, the link to the organisation's website has been followed 84 times Recent Search Terms used to find this page: Elixir Pharma One Kendall SquareBuilding 1000 Fifth Floor | elixir pharmaceuticals 2009 | elixir pharm 2009 | Elixir pharmaceuticals 2009 | . Search for more companies in Cambridge Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Elixir Pharmaceuticals, Inc | ||||||||||||||||||||||||||||||||||||||||||||||||||
|